Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression

Bopp, Sandra K.; Heilbronner, Urs; Schlattmann, Peter; Muehleisen, Thomas W.; Bschor, Tom; Richter, Christoph; Steinacher, Bruno; Stamm, Thomas J.; Merkl, Angela; Herms, Stefan; Köhler, Stephan; Sterzer, Philipp; Hellweg, Rainer; Heinz, Andreas; Cichon, Sven; Lang, Undine E.; Schulze, Thomas G.; Adli, Mazda und Ricken, Roland (2019): Leptin gene polymorphisms are associated with weight gain during lithium augmentation in patients with major depression. In: European Neuropsychopharmacology, Bd. 29, Nr. 2: S. 211-221

Abstract

Weight gain is a common adverse effect of lithium augmentation. Previous studies indicate an impact of genetic variants at the leptin gene on weight gain as a consequence of psychopharmacological treatment. The primary aim of our study was to identify variants at the leptin locus that might predict lithium-induced weight gain. The secondary aim was to investigate if these variants modulate leptin levels. In 180 patients with acute major depressive disorder, body mass index was measured before and after 4 weeks of lithium augmentation, in a subsample also after 4 and/or 7 months. In a subsample of 89 patients, leptin serum concentrations were measured before and during lithium augmentation. We used linear mixed model analyzes to investigate the effects of 2 polymorphisms at the leptin locus (rs4731426 and rs7799039, employing the respective proxy SNPs rs2278815 and rs10487506) on changes in body mass index and leptin levels. For both polymorphisms, which are in high linkage disequilibrium, body mass index was significantly lower in homozygous A-allele carriers than in carriers of other genotypes at baseline. Over the follow-up period, body mass index increased less in homozygous A-allele carriers of rs4731426 than in carriers of other genotypes. This was not the case for rs7799039. Neither polymorphism modulated leptin protein expression. Our study strongly supports the hypothesis that genetic variability at the leptin locus is involved in lithium augmentation-associated weight gain in major depressive disorder. Furthermore, Genotype-Tissue Expression data provide strong evidence that rs4731426 influences the expression of leptin messenger ribonucleic acid in fibroblasts. (c) 2018 Published by Elsevier B.V.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0924-977X
• Sprache: Englisch